PFIZER, targeting $50! Upside Prospect ON!
Updated
PFE weekly data is conveying significant accumulation at the current price range.
Net positive volume has been increasing on a daily basis for the past few days -- in anticipation of the company's incoming price growth, long term.
The stock is currently sitting at 78.6 FIB level -- a discounted level where buyers converge.
Expect some significant bounce from the current range with initial target to $50.
Weekly higher lows on histogram has been registered. Trend shift is about to commence.
First Bubble up volume appearance in almost 2 months.
Spotted at 38.0
TAYOR
Safeguard capital always.
Net positive volume has been increasing on a daily basis for the past few days -- in anticipation of the company's incoming price growth, long term.
The stock is currently sitting at 78.6 FIB level -- a discounted level where buyers converge.
Expect some significant bounce from the current range with initial target to $50.
Weekly higher lows on histogram has been registered. Trend shift is about to commence.
First Bubble up volume appearance in almost 2 months.
Spotted at 38.0
TAYOR
Safeguard capital always.
Trade active
moving as planned. more to go.Trade active
Nothing's changed. Still ranging at a solid support. Imminent price surge is in order based on weekly data.
Trade active
WEEKLY DATA : Breaking out on weekly.
Spotted at 36.38
Trade active
PFE may seem low key for most -- but it has a definite plan: GO UP.From the monthly data, last two candle bars bottomlines are already aligning -- hinting of a significant upside reversal soon.
Spotted at 35.0
Trade active
STRONG BUY ALERT!Long term BIG SHIFT has been spotted.
First time this alert surfaces since December 2022.
Massive growth awaits PFE.
Target set at X2 - 50 range.
TAYOR.
Trade active
STRONG BUY / KEEP HOLDING IF YOU HAVE IT.Trade active
Trade active
PFE has started breaking its long term downtrend.
Expect a series of price growth from the current levels of 28.0
Interim target set at 50.0
TAYOR.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.